Ironwood Pharmaceuticals buy Wells Fargo & Company
Start price
01.03.24
/
50%
€8.40
Target price
01.03.25
€12.91
Performance (%)
-12.50%
Price
15.04.24
€7.35
Summary
This prediction is currently active. The prediction for Ironwood Pharmaceuticals disappoints with a performance of -12.50%. This prediction currently runs until 01.03.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ironwood Pharmaceuticals | - | - |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ironwood Pharmaceuticals diskutieren
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target lowered by analysts at Wells Fargo & Company from $20.00 to $14.00. They now have an "overweight" rating on the stock.
Ratings data for IRWD provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Start price
Target price
Perf. (%)
€10.20
14.12.23
14.12.23
€18.27
14.12.24
14.12.24
-27.94%
15.04.24
15.04.24
